16 September 2022 · A summary of the implications of the UKs exit from the EU for clinical trial sites for both IMP and ATIMPs, including supply to and from Northern Ireland
7 March 2022 · This summary explains why it is not permitted for a Local Authority to delegate the authorisation of PGDs to a CCG using a Section 75 partnership agreement.
22 February 2022 · Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.
22 February 2022 · Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input
22 February 2022 · Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input